Browsing: Biotech

Partnership targets cold-chain bottlenecks by combining hydrogel preservation with human-relevant organoid platforms. Atelerix, a UK-based biotech focused on non-cryogenic cell…

Zealand Pharma partners Shanghai-based OTR Therapeutics in discovery deal focused on obesity and metabolic disease. Danish biotech Zealand Pharma has…

Survey finds C-suite sentiment improving, dealmaking rebounding, and hiring plans warming, even as the FDA clouds the outlook. Biotech executives…

Organoid, illustration. [Juan Gaertner/Science Photo Library/Getty Images] Atelerix, a biotech company working on cell preservation and biological transport with its…

TCI Biotech has opened the TCI Advanced Performance Nutrition Research Center in Salt Lake City, Utah, US. The new innovation…

MindImmune targets clinical trials of drug that blocks the harmful recruitment of peripheral immune cells into the brain. US biotech…

General Control enters Novo Nordisk’s Co-Creation Greenhouse to advance multiplex epigenetic editing for complex chronic disease. General Control, a previously…

Binance’s venture arm backs Renewal Bio’s mission to harness stem cells’ innate potential to redefine repair and renewal of human…

Credit: imaginima / iStock / Getty Images Plus Jonathan D. Grinstein, PhD, North American Editor of Inside Precision Medicine, hosts a…

Muna Therapeutics targets brain resilience with drug designed to enhance neural health by harnessing established protective mechanisms. Denmark’s Muna Therapeutics…